Publications by authors named "Alexander Dew"

Claim this Profile
R
Racial disparity in Non-Hodgkin Lymphoma: Parallel survival analysis with data from the DoD central cancer registry and SEER.
Jie Lin, Alexander A Dew, Craig D Shriver, Kangmin Zhu

Ann Epidemiol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Cancer Risk of US Service Members Exposed to Burn Pits in Iraq.
Ian Robertson, Robert Sgrignoli, Alexander Dew, Sarah Darmon, Ola Landgren

JAMA Netw Open· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival Among Patients With Multiple Myeloma in the United States Military Health System Compared to the Surveillance, Epidemiology, and End Results (SEER) Program.
Alexander Dew, Jie Lin, Sarah Darmon, Joe Roswarski, Craig Shriver

Clin Lymphoma Myeloma Leuk· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering Myeloma: A Phase 2 Nonrandomized Controlled Trial.
Dickran Kazandjian, Elizabeth Hill, Alexander Dew, Candis Morrison, Joseph Roswarski

JAMA Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnostic performance of F-FDG-PET/CT compared to standard skeletal survey for detecting bone destruction in smouldering multiple myeloma: time to move forward.
Elizabeth Hill, Esther Mena, Candis Morrison, Alexander Dew, Peter Choyke

Br J Haematol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma.
Dickran Kazandjian, Alexander Dew, Elizabeth Hill, Elizabeth Gil Ramirez, Candis Morrison

Oncologist· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Discordance Among Smoldering Multiple Myeloma Risk Models.
Elizabeth Hill, Alexander Dew, Candis Morrison, Constance Yuan, Maryalice Stetler-Stevenson

JAMA Oncol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The changing role of high dose melphalan with stem cell rescue in the treatment of newly diagnosed multiple myeloma in the era of modern therapies-back to the future!
Dickran Kazandjian, Alexander Dew, Elizabeth Hill

Best Pract Res Clin Haematol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia.
Stuart J Wong, Bruce Campbell, Becky Massey, Denis P Lynch, Ezra E W Cohen, Alexander Dew

Oral Oncol· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial.
Alexander Dew, Seema Khan, Christie Babinski, Nancy Michel, Marie Heffernan

Clin Trials· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial.
Seema A Khan, Robert T Chatterton, Nancy Michel, Michelle Bryk, Oukseub Lee, Alexander Dew

Cancer Prev Res (Phila)· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Methyl selenocysteine: single-dose pharmacokinetics in men.
James R Marshall, Clement Ip, Karen Romano, Gerald Fetterly, Marwan Fakih, Alexander Dew

Cancer Prev Res (Phila)· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stem-cell transplantation for sickle cell disease.
Alexander Dew, Koen van Besien

N Engl J Med· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence.
Koen van Besien, Alexander Dew, Shang Lin, Loren Joseph, Lucy A Godley

Leuk Lymphoma· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options.
Alexander Dew, Demetria Collins, Andrew Artz, Elizabeth Rich, Wendy Stock

Biol Blood Marrow Transplant· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis